Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn ’s disease and ulcerative colitis included in randomised controlled trials

While indirect comparison of infliximab (IFX) and vedolizumab (VDZ) in adults with Crohn ’s disease (CD) or ulcerative colitis (UC) shows that IFX has better effectiveness during induction, and comparable effic...

Source: BMC Gastroenterology - March 27, 2024 Category: Gastroenterology Authors: Laurent Peyrin ‐Biroulet, Perttu Arkkila, Alessandro Armuzzi, Silvio Danese, Marc Ferrante, Jordi Guardiola, Jørgen Jahnsen, Edouard Louis, Milan Lukáš, Walter Reinisch, Xavier Roblin, Philip J Smith, Taek Kwon, Jeeyoung Kim, Sangwook Yoon, Dong-Hye Tags: Research Source Type: research